News|Articles|June 20, 2026

Creating Capacity for Care: How Technology is Supporting Community Pharmacies

This article was sponsored by McKesson

Independent community pharmacies are being asked to do more than ever. Once viewed primarily as points of dispensing, they are increasingly serving as vital points of care in their communities that support a variety of patient needs, from medication management and chronic disease services to preventive care. This evolution is being driven by shifting market dynamics and patient needs and supported by technology that can help create additional capacity for higher value, permissible clinical and patient support activities.

As pharmacies navigate this shift, technology is becoming increasingly essential to success. But the goal isn’t just more tech; it’s better outcomes. The most effective investments are those that simplify day‑to‑day operations, reduce friction in workflows and help create capacity for pharmacists to spend more time caring for patients.

From fragmented systems to connected ecosystems

Over the last decade, we’ve moved from fragmented, transaction‑based pharmacy systems toward more connected digital ecosystems that link ordering, inventory management, clinical insights and patient engagement. For independent pharmacies in particular, this integration is critical.

Data-driven inventory solutions can help ensure essential medications are available when patients need them, while reducing excess stock and protecting cash flow. Platforms like Supplylogix, which are designed to help pharmacies operate more efficiently with tighter inventory control, help to minimize manual oversight by aligning inventory with projected demand and usage patterns.

Solutions such as Pinpoint Community Solutions are designed to apply these same inventory optimization principles in a way that is accessible to independent pharmacies. At the same time, services like Central Fill as a Service™, which helps manage peak volume and staffing constraints, allow pharmacies to offload high-volume dispensing without major infrastructure investments. Over time, these operational improvements can help expand a pharmacy’s capacity to focus on patient counseling, adherence support and higher value clinical services (where applicable). These capabilities are increasingly being delivered through integrated pharmacy platforms that bring together dispensing, inventory and operational workflows.

AI's role in unlocking efficiency*

Artificial intelligence is playing a notable role in this transformation, particularly when it is applied to routine, time‑consuming tasks. In pharmacy settings, AI‑driven tools can support inventory optimization, reduce time spent on routine administrative tasks and help surface workflow priorities based on real‑time demand for pharmacist review.

We’re also seeing strong interest in AI‑powered patient engagement solutions that allow pharmacies to maintain meaningful connections with patients beyond the counter. Virtual pharmacy assistants, for example, can answer administrative questions, provide refill updates and support basic requests, while routing clinical or medication-related inquiries to a pharmacist. This reduces incoming phone volume, minimizes disruptions to pharmacy workflows and creates an improved patient experience, without replacing the pharmacist‑patient relationship. Importantly, these tools do not replace pharmacist expertise, but give them time back to focus on patients and complex clinical needs.

Turning operational efficiency into better outcomes

The connection between operational efficiency and patient outcomes is increasingly being recognized. Adherence, access and patient satisfaction are all influenced by how smoothly a pharmacy operates.

Technology can help surface potential patients who may need additional support. Analytics can help identify potential gaps in adherence or highlight patients with complex regimens who could benefit from medication therapy management or other clinical services. This allows pharmacists to intervene earlier, provide personalized guidance and help prevent downstream complications.

For independent pharmacies, these capabilities support both patient care and sustainability. Pharmacies that invest strategically in digital infrastructure are better positioned to expand service offerings, build patient loyalty and adapt to changing reimbursement and regulatory environments. The long‑term value comes not just from cost savings, but from creating a resilient, patient‑centered model of care. This is especially important as independent pharmacies navigate tighter margins and shifting reimbursement pressures, where efficiency isn’t just helpful, it’s essential to staying sustainable.

Aligning technology decisions with patient impact

Not every innovation will be right for every pharmacy. The key is intentional adoption, and selecting tools that align with a pharmacy’s size, workflow and patient population. Programs and partners that allow pharmacies to evaluate emerging technologies before making significant investments can play an important role here, helping teams stay current without unnecessary risk.

What we see consistently is that pharmacies who are shifting from reactive technology adoption to strategic digital investment are positioned to see stronger returns. They are streamlining operations, strengthening their role in the community and building the flexibility needed to evolve alongside the healthcare system.

Technology alone will not redefine pharmacy care, but when used thoughtfully, it can unlock clinical innovation and restore time to focus on what matters most: caring for patients. By reducing administrative burden and simplifying workflows, technology can serve as a catalyst for strengthening outcomes, deepening relationships with patients and reinforcing the role of community pharmacies as essential healthcare partners.

*These AI‑enabled tools are designed to support, not replace, pharmacist judgment, and operate within defined workflows and appropriate human oversight. In patient‑facing contexts, they should clearly disclose their AI‑supported nature and escalate to pharmacy staff when appropriate.


Latest CME